National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 2 of 2 Research Studies DisplayedRikin S, Perez HR, Zhang C
Changes in outpatient opioid prescribing during the COVID-19 pandemic: an interrupted time series analysis.
Changes in health care delivery during the COVID-19 pandemic may have impacted opioid prescribing. This study evaluated the impact of restrictions on in-person care on opioid prescribing in the outpatient setting. The hypothesis was that after restrictions to in-person care were implemented, there would be a reduction in the number of chronic and non-chronic opioid prescriptions.
AHRQ-funded; HS026396.
Citation: Rikin S, Perez HR, Zhang C .
Changes in outpatient opioid prescribing during the COVID-19 pandemic: an interrupted time series analysis.
J Prim Care Community Health 2022 Jan-Dec;13:21501319221076926. doi: 10.1177/21501319221076926..
Keywords: COVID-19, Opioids, Medication, Practice Patterns, Healthcare Delivery
Levin Z, Chang J, Karaca-Mandic P
Characteristics of hydroxychloroquine dispensing in the United States, January to May 2020.
This research letter describes a comparison of hydroxychloroquine (HCQ) prescription trends from January to May 2020. The authors identified HCQ dispensing from the OptumLabs Data Warehouse and identified 66,253 enrollees with 134,417 HCQ fills during the study period. Nearly 13,000 new fillers (67.2%) did not have a diagnostic indication of lupus, rheumatoid arthritis, malaria or Sjogren’s syndrome. Among previous fillers, 15.1% had no indication. The most common diagnosis was RA among indicated users. The rate of HCQ fills per 1,000 enrollees increased substantially in mid-March among both new and previous HCQ fillers. For prior fillers, rates increased due to an anticipated shortage of the drug due to people using it for COVID-19 prevention.
AHRQ-funded; HS025164.
Citation: Levin Z, Chang J, Karaca-Mandic P .
Characteristics of hydroxychloroquine dispensing in the United States, January to May 2020.
J Gen Intern Med 2022 Jan;37(1):176-78. doi: 10.1007/s11606-021-07175-9..
Keywords: COVID-19, Medication, Practice Patterns